Cover Image
市場調查報告書

全球再生醫療市場:各產品、治療方法、用途、地區 - 成長,趨勢,預測(2018年∼2023年)

Global Regenerative Medicine Market - Segmented by Type of Products, Therapy and Applications - Growth, Trends and Forecasts (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 613022
出版日期 內容資訊 英文 113 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球再生醫療市場:各產品、治療方法、用途、地區 - 成長,趨勢,預測(2018年∼2023年) Global Regenerative Medicine Market - Segmented by Type of Products, Therapy and Applications - Growth, Trends and Forecasts (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 113 Pages
簡介

全球再生醫療市場,預計從2018年到2023年以14%的年複合成長率發展,到2023年達到42億3,000萬美元。各地區中,有許多先進技術的北美成為最大市場。

本報告提供全球再生醫療市場調查,市場概要,各技術類型、應用領域、地區的市場趨勢,市場規模的變化與預測,市場佔有率,市場促進、阻礙因素以及市場機會、課題分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要推論

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 市場動態

  • 推動市場要素
    • 幹細胞技術的引進增加
    • 再生醫療的技術性優點
  • 市場阻礙因素
    • 倫理的及法規上的問題
    • 治療費高和認識低
  • 市場機會
  • 主要課題

第7章 全球再生醫療市場:市場區隔

  • 各技術類型
    • 幹細胞治療
    • 生物材料
    • 組織工程
  • 各應用領域
    • 替代骨
    • 骨關節疾病
    • 皮膚
    • 心臟血管系統
    • 中樞神經系統
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • M&A
  • 協定,合作,聯盟
  • 新產品的上市

第9章 主要企業

  • ACELITY
  • OSIRIS THERAPEUTICS
  • INTEGRA LIFESCIENCES CORPORATION
  • COOK BIOTECH INCORPORATED
  • ORGANOGENESIS INC
  • MERCK & CO
  • 其他的主要企業

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 5405

The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements.

Increasing adoption of stem cell technology

Increasing adoption of stem cell technology, increasing prevalence of chronic diseases, emerging applications of gene therapy in regenerative medicine are some of the driving factors for Global Regenerative Medicine market. Technological advances in regenerative medicine (stem cell, tissue engineering, and nanotechnology) and high investment & funding to support development of regenerative medicine are also fuelling the market growth.

Regulatory and ethical issues

Regulatory and ethical issues pertaining stem cell, tissues engineering and regenerative medicine are acting as a restraint for Regenerative Medicine market. High cost of treatments and less awareness about the regenerative medicine among people is further restraining the market.

North America to Dominate the Market

The Regenerative Medicine market is segmented by type of treatment and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.

North America dominates the Regenerative Medicine market due to the increasing technological advancements and high investment & funding to support development of regenerative medicine. Asia-Pacific is also expected to propel the Regenerative Medicine market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing economic growth.

Key developments in the market

In January, 2018: Medeor Therapeutics Awarded $18.8 Million From the California Institute for Regenerative Medicine

In January, 2018: RepliCel Life Sciences Inc. formed a partnership with the private firm, China-based Yofoto Health Industry Co. Ltd for regenerative medicine

Major key players: ACELITY, OSIRIS THERAPEUTICS, INC., INTEGRA LIFESCIENCES CORPORATION, ASTRAZENECA, COOK BIOTECH INCORPORATED, ORGANOGENESIS INC. and MERCK & CO., INC. etc.

Reasons to purchase this report

Market analysis for the Global Regenerative Medicine Market, with region-specific assessments and competition analysis on a global and regional scale.

Analyzing various perspectives of the company with the help of Porter's five forces analysis

The treatment type that is expected to dominate the market

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares and strategies employed by the major market players.

3 months analyst support along with the Market Estimate sheet in excel.

Customization of the report

This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Table of Contents

1. INTRODUCTION

  • 1.1 MARKET DEFINITION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW

  • 5.1 CURRENT MARKET SCENARIO
  • 5.2 PORTER'S FIVE FORCES
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF CONSUMERS
    • 5.2.3 THREATS OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
    • 5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY

6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)

  • 6.1 MARKET DRIVERS
    • 6.1.1 INCREASING ADOPTION OF STEM CELL TECHNOLOGY
    • 6.1.2 TECHNOLOGICAL ADVANCES IN REGENERATIVE MEDICINE
  • 6.2 MARKET RESTRAINTS
    • 6.2.1 REGULATORY AND ETHICAL ISSUES
    • 6.2.2 HIGH COST OF TREATMENTS AND LESS AWARENESS
  • 6.3 OPPORTUNITIES
  • 6.4 KEY CHALLENGES

7. MARKET SEGMENTATION

  • 7.1 BY TYPE OF TECHNOLOGY
    • 7.1.1 STEM CELL THERAPY
    • 7.1.2 BIOMATERIAL
    • 7.1.3 TISSUE ENGINEERING
  • 7.2 BY TYPE OF APPLICATIONS
    • 7.2.1 BONE GRAFT SUBSTITUTES
    • 7.2.2 OSTEOARTICULAR DISEASES
    • 7.2.3 DERMATOLOGY
    • 7.2.4 CARDIOVASCULAR
    • 7.2.5 CENTRAL NERVOUS SYSTEM
  • 7.3 BY GEOGRAPHY
    • 7.3.1 NORTH AMERICA
      • 7.3.1.1 US
      • 7.3.1.2 CANADA
      • 7.3.1.3 MEXICO
    • 7.3.2 EUROPE
      • 7.3.2.1 FRANCE
      • 7.3.2.2 UK
      • 7.3.2.3 GERMANY
      • 7.3.2.4 ITALY
      • 7.3.2.5 SPAIN
      • 7.3.2.6 REST OF EUROPE
    • 7.3.3 ASIA-PACIFIC
      • 7.3.3.1 INDIA
      • 7.3.3.2 CHINA
      • 7.3.3.3 JAPAN
      • 7.3.3.4 AUSTRALIA
      • 7.3.3.5 SOUTH KOREA
      • 7.3.3.6 REST OF APAC
    • 7.3.4 MIDDLE EAST AND AFRICA
      • 7.3.4.1 GCC
      • 7.3.4.2 SOUTH AFRICA
      • 7.3.4.3 REST OF MIDDLE EAST AND AFRICA
    • 7.3.5 SOUTH AMERICA
      • 7.3.5.1 BRAZIL
      • 7.3.5.2 ARGENTINA
      • 7.3.5.3 REST OF SOUTH AMERICA

8. COMPETITIVE LANDSCAPE

  • 8.1 MERGERS AND ACQUISITIONS
  • 8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
  • 8.3 NEW PRODUCT LAUNCHES

9. KEY PLAYERS

  • 9.1 ACELITY
  • 9.2 OSIRIS THERAPEUTICS
  • 9.3 INTEGRA LIFESCIENCES CORPORATION
  • 9.4 COOK BIOTECH INCORPORATED
  • 9.5 ORGANOGENESIS INC
  • 9.6 MERCK & CO
  • 9.7 OTHERS

10. FUTURE OUTLOOK OF THE MARKET

Back to Top